One challenge in vaccine growth is financial: Many of the disorders most demanding a vaccine, like HIV, malaria and tuberculosis, exist principally in very poor international locations. Pharmaceutical companies and biotechnology companies have minor incentive to produce vaccines for these diseases mainly because There exists small profits prospecti